Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2021

  1. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

2016

  1. Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome

    Pharmacology Research and Perspectives, Vol. 4, Núm. 2

2015

  1. Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson's disease

    Neuroscience Letters, Vol. 587, pp. 1-4